Form 4: CorMedix COO Reports Stock Sale, Cites Admin Error
Insider Transaction Report
CorMedix Inc.'s Chief Operating Officer, Elizabeth Hurlburt, reported the disposition of 5,794 shares of common stock at $7.15 per share, attributing the late filing to an administrative error.
Summary
- Elizabeth Hurlburt, EVP and Chief Operating Officer of CorMedix Inc. (CRMD), disposed of 5,794 shares of common stock.
- The transaction occurred on January 12, 2026, at a price of $7.15 per share.
- Following this transaction, Hurlburt beneficially owns 160,301 shares of CorMedix common stock directly.
- The filing of this Form 4 was delayed due to an inadvertent administrative error.
- A Power of Attorney was granted by Elizabeth Hurlburt to Beth Zelnick Kaufman on January 14, 2026, authorizing her to prepare and file SEC forms on Hurlburt's behalf.
Sentiment
Score: 5
Explanation: The filing reports a standard insider stock disposition, with the only notable aspect being a late filing attributed to an administrative error, which is a minor compliance issue. Overall, it is a neutral event.
Negatives
- The Form 4 filing was reported late due to an inadvertent administrative error, indicating a minor compliance issue.
Risks
- A minor compliance risk due to the late filing of the Form 4, attributed to an administrative error.
Future Outlook
NA
Management Comments
- "This transaction is being reported late due to an inadvertent administrative error."
Industry Context
This filing reports an individual insider transaction by an executive, which is a routine disclosure and does not directly reflect broader industry trends or competitive dynamics.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Authorization for SEC Filings | Elizabeth Hurlburt granted Beth Zelnick Kaufman a Power of Attorney to prepare, execute, submit, and file SEC Forms ID, 3, 4, 5, and 144 on her behalf. | January 14, 2026 | Streamlines the process for Elizabeth Hurlburt to comply with her Section 16 and Rule 144 reporting obligations as an officer and director of CorMedix Inc., enhancing efficiency in regulatory compliance. |
Related Party Transactions
- The disposition of common stock by Elizabeth Hurlburt, an EVP and Chief Operating Officer of CorMedix Inc., constitutes an insider transaction.
Stakeholder Impact
- Shareholders: The disposition of 5,794 shares by an executive is a relatively small transaction and is unlikely to have a significant impact on the company's stock price or long-term value. The late filing is a minor compliance note.
Key Dates
| Date | Description |
|---|---|
| 01/12/2026 | Date of transaction (disposition of common stock by Elizabeth Hurlburt). |
| 01/14/2026 | Date Elizabeth Hurlburt executed the Power of Attorney to Beth Zelnick Kaufman. |
| 01/20/2026 | Date the Form 4 was signed and filed with the SEC. |
Recommendation
holdThis filing is a routine insider transaction report (Form 4) detailing a disposition of shares by an executive. While the filing was late due to an administrative error, the transaction itself is not substantial enough to warrant a change in investment recommendation. Investors should consider broader company fundamentals and market conditions rather than this isolated event.
Keywords
CorMedix, CRMD, insider transaction, stock sale, Form 4, beneficial ownership, executive compensation, Elizabeth Hurlburt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.